PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33920736-0	2021	Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells.	pulvomycin	22-32	signal transducer and activator of transcription 3	Mus musculus	57-62	
33920736-4	2021	In this study, a docetaxel-resistant TNBC cell line (MDA-MB-231-DTR) was established, and mechanisms for the antitumor activity of pulvomycin, a novel STAT3 inhibitor isolated from marine-derived actinomycete, were investigated.	pulvomycin	131-141	signal transducer and activator of transcription 3	Mus musculus	151-156	
33920736-7	2021	In addition, pulvomycin suppressed the activation of STAT3 and subsequently induced G0/G1 cell cycle arrest and apoptosis.	pulvomycin	13-23	signal transducer and activator of transcription 3	Mus musculus	53-58	
33920736-9	2021	In an MDA-MB-231-DTR-bearing xenograft mouse model, the combination of pulvomycin and docetaxel effectively inhibited tumor growth through STAT3 regulation.	pulvomycin	71-81	signal transducer and activator of transcription 3	Mus musculus	139-144